Table 1 Patient data of the treated patients
From: Performance of gimbal-based dynamic tumor tracking for treating liver carcinoma
ID | Age | Sex | Tumor | Volume PTV [ccm] | Plan Type | Dose [Gy] | Fractions |
|---|---|---|---|---|---|---|---|
204 | 88 | m | HCC G2 | 271.98 | Conformal | 60.0 | 10 |
204* | 90 | m | HCC | 55.67 | Conformal | 48.0 | 8 |
206 | 52 | m | liver metastasis | 251.26 | Conformal | 72.0 | 12 |
207 | 75 | m | HCC G3 | 52.03 | Conformal | 72.0 | 12 |
209 | 67 | m | liver metastasis | 1013.12 | IMRT | 48.0 | 8 |
210 | 54 | m | liver metastasis | 31.21 | Conformal | 40.0 | 10 |
211 | 73 | w | liver metastasis | 106.26 | Conformal | 72.0 | 12 |
212 | 73 | w | liver metastasis | 925.08 | IMRT | 72.0 | 12 |
213 | 54 | m | liver metastasis | 72.21 | Conformal | 72.0 | 12 |
214 | 51 | m | liver metastasis | 230.97 | Conformal | 72.0 | 12 |
215 | 70 | m | liver metastasis | 64.03 | Conformal | 72.0 | 12 |
216 | 77 | m | liver metastasis | 56.76 | Conformal | 72.0 | 12 |
217 | 85 | m | HCC | 204.53 | IMRT | 72.0 | 12 |